Skip to content

Comparison of Noninvasive Hemoglobin Disposable Sensors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03125031
Enrollment
44
Registered
2017-04-24
Start date
2014-07-10
Completion date
2014-07-25
Last updated
2017-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of two noninvasive hemoglobin sensors will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.

Interventions

DEVICERainbow adhesive adult/pediatric sensor
DEVICERainbow adhesive adult/neonatal sensor

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female * 18-40 years of age * Weight of at least 110 lbs and less than 250 lbs for subjects under 6 feet tall. * Physical status of ASA I of II * Able to read and communicate in English * Has signed written informed consent * Female, non pregnant.

Exclusion criteria

* Age less than 18 yrs and greater than 40 years * If the Warming and cooling subjects have open cuts of skin abrasions on their extremities they will be excluded because alcohol spray may be painful. * Weight of less than 110 lbs or more than 250 lbs if the subject is less than 6 feet tall. * Hemoglobin less than 11 g/dL * ASA physical status of III. IV, V. * Pregnant * Subject has known drug or alcohol abuse * Subject has skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails. * Subject has experienced a head injury with loss of consciousness within the last year. * Subject has known neurological and psychiatric disorder that interferes with the subjects' level of consciousness. * Known or concurrent chronic usage of psychoactive or anticonvulsive drugs within the last 90 days, or any use in the last 7 day (i.e. tricyclic antidepressants, MAO inhibitors, Lithum, neuroleptics, anxiolytics or antipsychotics, except SSRIs). * Subject has any medical condition which in the judgment of the investigator, renders them inappropriate for participation in this study, such as Reynauds Syndrome. * Systolic BP \>140 mmHg or Diastolic BP \> 100 mmHg. * Baseline heart rate \< 50 bpm. * Inability to tolerate sitting still or minimal movement for up to 90 minutes * Discretion of investigator

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Noninvasive Sensors by Arms Calculation1-5 hoursAccuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square (Arms) error value. The accuracy results from both sensors will be assessed for equivalence

Countries

United States

Participant flow

Participants by arm

ArmCount
Rainbow Adhesive Adult/Pediatric and Adult/Neonatal Sensors
All subjects are enrolled into the test group and receive the Rainbow adhesive sensors (adult/pediatric and adult/neonatal sensors).
44
Total44

Baseline characteristics

CharacteristicRainbow Adhesive Adult/Pediatric and Adult/Neonatal Sensors
Age, Customized
18-38 years
44 Participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
32 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 44
serious
Total, serious adverse events
0 / 44

Outcome results

Primary

Accuracy of Noninvasive Sensors by Arms Calculation

Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square (Arms) error value. The accuracy results from both sensors will be assessed for equivalence

Time frame: 1-5 hours

ArmMeasureValue (NUMBER)
Group-Sensor 1Accuracy of Noninvasive Sensors by Arms Calculation1.0 g/dL
Group-Sensor 2Accuracy of Noninvasive Sensors by Arms Calculation1.0 g/dL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026